Best SBA 7(a) lenders for medicinal and botanical manufacturing
The top SBA 7(a) lenders for medicinal and botanical manufacturing (NAICS 325411) are TD Bank, National Association, CDC Small Business Finance Corp., MISSINGMAINBANKID, ranked by loan volume. Between FY2020 and Q1 FY2026 (2025-12-31), the SBA 7(a) program approved 107 loans totaling $87.0M to businesses in this industry. Average loan size: $813K. Average rate: 8.23%. Industry-wide charge-off rate (FY2020–FY2023 cohort): 3.03%.
Loans
107
Total $
$87.0M
Avg loan
$813K
Avg rate
8.23%
Avg term
134 mo
Industry chg-off rate
3.03%
FY20–FY23 cohort
Top 15 lenders in this industry
| # | Lender | Loans | Total $ | Avg loan | Avg rate | Chg-off % |
|---|---|---|---|---|---|---|
| 1 | TD Bank, National Association | 7 | $1.8M | $250K | 8.16% | 20.00% |
| 2 | CDC Small Business Finance Corp. | 6 | $1.2M | $202K | 11.00% | 33.33% |
| 3 | MISSINGMAINBANKID | 6 | $8.8M | $1.5M | 6.79% | 0.00% |
| 4 | Newtek Bank, National Association | 6 | $5.5M | $911K | 11.58% | 0.00% |
| 5 | Manufacturers and Traders Trust Company | 4 | $988K | $247K | 6.44% | 0.00% |
| 6 | Central Bank | 4 | $4.6M | $1.1M | 10.31% | — |
| 7 | Choice Financial Group | 4 | $3.5M | $875K | 4.75% | 0.00% |
| 8 | Provident Bank | 4 | $5.4M | $1.4M | 6.38% | 0.00% |
| 9 | InBank | 3 | $8.1M | $2.7M | 9.00% | — |
| 10 | Genisys CU | 3 | $5.4M | $1.8M | 8.58% | 0.00% |
| 11 | KeyBank National Association | 3 | $2.4M | $803K | 6.00% | 0.00% |
| 12 | The Huntington National Bank | 3 | $1.4M | $457K | 9.00% | 0.00% |
| 13 | Washington Trust Bank | 3 | $825K | $275K | 11.17% | 0.00% |
| 14 | Eastern Bank | 3 | $550K | $183K | 7.75% | 0.00% |
| 15 | BayFirst National Bank | 2 | $245K | $123K | 10.75% | 0.00% |
Get matched with SBA lenders — free
Tell us a bit about your funding need. We'll connect you to SBA-preferred lenders active in your industry and state. No obligation.
Methodology
Computed from the SBA 7(a) FOIA dataset (as of 2025-12-31), filtered to NAICS code 325411. Charge-off rates are calculated on the FY2020–FY2023 cohort only.